Skip to main content

Table 1 Patients characteristics and scores on their general attitudes towards deprescribing subdivided by therapeutic area

From: Older people’s attitudes towards deprescribing cardiometabolic medication

 

Total

Diabetes areaa

Cardiovascular areaa

Number of participants

314

91

223

Age (years), median (IQR)

76 (IQR:73–80)

76 (IQR:73–80)

75 (IQR:73–80)

Sex, n (%)

 Female

118 (38%)

34 (37%)

84 (38%)

 Male

192 (61%)

57 (63%)

135 (61%)

 Unknown

4 (1%)

0 (0%)

4 (2%)

Number of medication, n (%)

 1–5

151 (48%)

35 (38%)

116 (52%)

 6–10

137 (44%)

43 (47%)

94 (42%)

 > 10

26 (8%)

13 (14%)

13 (6%)

Satisfaction with medicationb

 Agree, n (%)

250 (80%)

76 (84%)

174 (78%)

 Neutral, n (%)

45 (14%)

8 (9%)

37 (17%)

 Disagree, n (%)

19 (6%)

7 (8%)

12 (5%)

Willingness to stopc

 Agree, n (%)

276 (88%)

83 (91%)

193 (87%)

 Neutral, n (%)

22 (7%)

5 (5%)

17 (8%)

 Disagree, n (%)

16 (5%)

3 (3%)

13 (6%)

Burden

 Mean (SD)

2.6 (0.62)

2.7 (0.69)

2.6 (0.58)

 Agree, n (%)

29 (9%)

15 (17%)

14 (6%)

 Neutral, n (%)

150 (48%)

38 (42%)

112 (50%)

 Disagree, n (%)

134 (43%)

37 (41%)

97 (44%)

Appropriateness

 Mean (SD)

3.7 (0.65)

3.6 (0.74)

3.7 (0.60)

 Agree, n (%)

128 (41%)

39 (43%)

89 (40%)

 Neutral, n (%)

148 (47%)

41 (45%)

107 (48%)

 Disagree, n (%)

36 (12%)

11 (12%)

25 (11%)

Concerns

 Mean (SD)

2.7 (0.62)

2.7 (0.67)

2.7 (0.59)

 Agree, n (%)

22 (7%)

6 (7%)

16 (7%)

 Neutral, n (%)

165 (53%)

49 (54%)

116 (53%)

 Disagree, n (%)

123 (40%)

35 (39%)

88 (40%)

Involvement

 Mean (SD)

3.9 (0.60)

3.9 (0.59)

4.0 (0.60)

 Agree, n (%)

266 (85%)

75 (82%)

191 (86%)

 Neutral, n (%)

35 (11%)

12 (13%)

23 (10%)

 Disagree, n (%)

11 (4%)

4 (4%)

7 (3%)

  1. The factor scores are reported as the mean (SD) of five Likert scale items and are categorised into disagree (1–2.5), neutral (2.6–3.5) and agree (3.6–5.0)
  2. aIn the diabetes area group, 72 (79%) participants reported that they were using a antihypertensive medication, 65 (71%) reported using a statin, 64 (70%) used a sulfonylurea and 33 (36%) used insulin. In the cardiovascular area group, all participants used at least one antihypertensive medication, a statin and no sulfonylurea or insulin
  3. bSatisfaction with medication: ‘Overall, I’m satisfied with my current medicines’
  4. cWillingness to stop: ‘If my doctor said it was possible, I would be willing to stop one or more of my regular medicines’